An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma

Table 4

Outcome measurements by visit (eyes with phacocanaloplasty).

Visit	IOP (mmHg)			Meds (number)			Visual acuity^1
	Mean ± SD	N	value	Mean ± SD	N	value	Mean ± SD	Snellen	N	value
Pre-op	18.1 ± 5.6	127		2.0 ± 1.1	127		0.41 ± 0.35	20/51.3	127
Day 1	12.9 ± 5.9	122	<0.001	0.0 ± 0.2	127	<0.001	0.91 ± 0.56	20/161.4	124	<0.0001
Wk 1	15.3 ± 6.6	125	<0.001	0.0 ± 0.3	127	<0.001	0.59 ± 0.40	20/78.5	127	<0.0001
Mo 1	12.0 ± 6.1	122	<0.001	0.1 ± 0.5	126	<0.001	0.39 ± 0.29	20/49.4	126	0.72
Mo 3	13.8 ± 5.7	107	<0.001	0.1 ± 0.4	105	<0.001	0.28 ± 0.28	20/37.8	108	<0.001
Mo 6	14.4 ± 4.6	93	<0.001	0.2 ± 0.6	96	<0.001	0.21 ± 0.28	20/32.6	95	<0.0001
Mo 12	14.4 ± 4.6	79	<0.001	0.4 ± 0.7	84	<0.001	0.20 ± 0.27	20/31.5	84	<0.0001
Mo 18	15.5 ± 4.8	78	<0.001	0.6 ± 0.9	68	<0.001	0.17 ± 0.22	20/29.9	83	<0.0001
Yr 2	14.7 ± 4.4	69	<0.001	0.6 ± 0.9	74	<0.001	0.18 ± 0.17	20/30.1	69	<0.0001
Yr 3	15.4 ± 4.0	27	0.002	0.7 ± 1.1	31	<0.001	0.24 ± 0.29	20/35.1	27	0.03

¹LogMAR unless indicated.